In addition to the animal model-based research, longitudinal studies involving a larger cohort of OSA patients are needed to assess the specificity and accuracy of IGFBP4 as a diagnostic and prognostic biomarker for OSA. Here, IGFBP4 is linked to obstructive sleep apnea syndrome.